Evidence map›Paper›PMID 24789782›Full record

ArticleJournal of virology2014

Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.

Julia Schwaiger, Judith H Aberle, Karin Stiasny, Bernhard Knapp, Wolfgang Schreiner, Ingrid Fae, Gottfried Fischer, Ondrej Scheinost, Vaclav Chmelik, Franz X Heinz

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Human T Cell Responses to Flavivirus Vaccines.European journal of immunology · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mucosal Vaccination: A Promising Alternative Against Flaviviruses.Frontiers in cellular and infection microbiology · 2022
    Review
  13. Article
  14. Review
  15. Cross-Reactive Immunity Among Flaviviruses.Frontiers in immunology · 2020
    Review
  16. Article
  17. Article
  18. CD4 T cell responses to flaviviruses.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2018
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Julia SchwaigerDepartment of Virology, Medical University of Vienna, Vienna, Austria.
Judith H AberleDepartment of Virology, Medical University of Vienna, Vienna, Austria.
Karin StiasnyDepartment of Virology, Medical University of Vienna, Vienna, Austria.
Bernhard KnappDepartment of Statistics, Protein Informatics Group, University of Oxford, Oxford, United Kingdom Section of Biosimulation and Bioinformatics, Medical University of Vienna, Vienna, Austria.
Wolfgang SchreinerSection of Biosimulation and Bioinformatics, Medical University of Vienna, Vienna, Austria.
Ingrid FaeDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Gottfried FischerDepartment of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
Ondrej ScheinostLaboratory of Molecular Genetics, Hospital České Budĕjovice, České Budĕjovice, Czech Republic.
Vaclav ChmelikDepartment of Infectious Diseases, Hospital České Budĕjovice, České Budĕjovice, Czech Republic.
Franz X HeinzDepartment of Virology, Medical University of Vienna, Vienna, Austria franz.x.heinz@meduniwien.ac.at.
Medical University of Vienna · ATNemocnice České Budějovice · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tick-borne encephalitis (TBE) virus is endemic in large parts of Europe and Central and Eastern Asia and causes more than 10,000 annual cases of neurological disease in humans. It is closely related to the mosquito-borne yellow fever, dengue, Japanese encephalitis, and West Nile viruses, and vaccination with an inactivated whole-virus vaccine can effectively prevent clinical disease. Neutralizing antibodies are directed to the viral envelope protein (E) and an accepted correlate of immunity. However, data on the specificities of CD4(+) T cells that recognize epitopes in the viral structural proteins and thus can provide direct help to the B cells producing E-specific antibodies are lacking. We therefore conducted a study on the CD4(+) T cell response against the virion proteins in vaccinated people in comparison to TBE patients. The data obtained with overlapping peptides in interleukin-2 (IL-2) enzyme-linked immunosorbent spot (ELISpot) assays were analyzed in relation to the three-dimensional structures of the capsid (C) and E proteins as well as to epitope predictions based on major histocompatibility complex (MHC) class II peptide affinities. In the C protein, peptides corresponding to two out of four alpha helices dominated the response in both vaccinees and patients, whereas in the E protein concordance of immunodominance was restricted to peptides of a single domain (domain III). Epitope predictions were much better for C than for E and were especially erroneous for the transmembrane regions. Our data provide evidence for a strong impact of protein structural features that influence peptide processing, contributing to the discrepancies observed between experimentally determined and computer-predicted CD4(+) T cell epitopes. Importance: Tick-borne encephalitis virus is endemic in large parts of Europe and Asia and causes more than 10,000 annual cases of neurological disease in humans. It is closely related to yellow fever, dengue, Japanese encephalitis, and West Nile viruses, and vaccination with an inactivated vaccine can effectively prevent disease. Both vaccination and natural infection induce the formation of antibodies to a viral surface protein that neutralize the infectivity of the virus and mediate protection. B lymphocytes synthesizing these antibodies require help from other lymphocytes (helper T cells) which recognize small peptides derived from proteins contained in the viral particle. Which of these peptides dominate immune responses to vaccination and infection, however, was unknown. In our study we demonstrate which parts of the proteins contribute most strongly to the helper T cell response, highlight specific weaknesses of currently available approaches for their prediction, and demonstrate similarities and differences between vaccination and infection.

Indexed as

AdolescentAdultAgedAged, 80 and overAntigens, ViralCD4-Positive T-LymphocytesEncephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneEnzyme-Linked Immunospot AssayEpitopesFemaleHumansInterleukin-2MaleMiddle AgedProtein ConformationAntigens, ViralEpitopesInterleukin-2Vaccines, InactivatedViral Vaccines

Identifiers

PMID24789782
PMCPMC4097808
OpenAlexW1966639864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.